Northwest Medical Specialties, PLLC — Tacoma, Washington

Public research footprint of Northwest Medical Specialties, PLLC, compiled from the ClinicalTrials.gov public registry.

259

Registered studies

134

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Ovarian Carcinoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT04181060 — Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With… (Recruiting)
NCT04589845 — Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You… (Active Not Recruiting)
NCT06058377 — Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Northwest Medical Specialties, PLLC?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.